Tuvalu
Tuberculosis profile
Population  2012 <1 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) <0.01 (<0.01–<0.01) 37 (16–68)
Mortality (HIV+TB only)        
Prevalence  (includes HIV+TB) 0.037 (0.017–0.065) 377 (172–658)
Incidence  (includes HIV+TB) 0.024 (0.019–0.029) 241 (196–290)
Incidence (HIV+TB only)        
Case detection, all forms (%) 80 (66–98)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 8 (42) Relapse 0 (0)
Smear-negative 2 (11) Treatment after failure 0 (0)
Smear-unknown / not done 0 (0) Treatment after default 1 (100)
Extrapulmonary 9 (47) Other 0 (0)
Other 0 (0)      
Total new 19   Total retreatment 1  
           
Other (history unknown) 0        
Total new and relapse 19   Total cases notified 20  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 0.6   3.5
Age < 15 2   2
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 75   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 88  
Retreatment    
TB/HIV 2012 Number (%)
TB patients with known HIV status 9 (45)
HIV-positive TB patients 0 (0)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 0  
HIV-positive TB patients on antiretroviral therapy (ART) 0  
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 4.9 (3.6–6.1) 23 (20–27)
MDR-TB cases among notified pulmonary
TB cases
0 (0–1) 0 (0–0)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 1 (11%)   1
Laboratory-confirmed MDR-TB cases 1   2
Patients started on MDR-TB treatment     1
Financing TB control 2013
National TB programme budget (US$ millions) <1
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-23 Data: www.who.int/tb/data